SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.77 CNY | -5.90% |
|
-10.24% | -34.01% |
| 30/05 | Labway Clinical Laboratory Names Chief Financial Officer | MT |
| 26/04 | Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 48Cr | - | - | - | - | - | |
| 791.07Cr | ||||||
| 451.56Cr | - | - | ||||
| 274.05Cr | ||||||
| 265.93Cr | ||||||
| 201.77Cr |
